Correlation of EGFR Expression with Survival Rate in Patients with Oral Squamous Cell Carcinoma

Authors

  • Fereshteh Baghai Naini Associate Professor, Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
  • Mahyar Ketabi Oral and Maxillofacial Pathologist, Tehran, Iran
  • Mohammad Ali Keshvad Student of Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
  • Mohammad Javad Kharrazifard Research Member, Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  • Neda Kardouni Khozestani Assistant Professor, Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
  • Pouria Motahhary Assistant Professor, Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
  • Sedigheh Rahrotaban Assistant Professor, Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
  • Seyed Yuosef Moosavi Salehi Periodontology Resident, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
Abstract:

Background and Aim: This study aimed to indicate the role of epidermal growth factor (EGF) in proliferation and growth of epithelial tissue and to determine the correlation be-tween the frequency of expression of EGF receptor (EGFR) by means of immunohistochemistry with survival rate in oral squamous cell carcinoma (OSCC). Materials and Methods: Thirty-eight cases of OSCC diagnosed by hematoxylin and eo-sin (H&E) staining were included in this prospective study, and immunohistochemistry for EGFR was applied using antibodies against EGFR. The total score of stained cells and the correlation between the total score and survival rate of patients were recorded. The data were analyzed by Kaplan-Meier, Spearman and the log rank tests using SPSS software version 20. Results: The mean age of patients was 71.8±1.09 years. The follow up range was 25-86 months. The mean survival time for EGFR score 3 (51±9.32 months) was significantly higher than that for score 4, (28.64±4.1 months) (P=0.002) and overexpression of EGFR was correlated with poor prognosis. A significant correlation was found between the grade of tumor and EGFR scale (P=0.049, R=0.318). There was no significant correlation between EGFR overexpression and OSCC stage (P>0.05). Conclusion: EGFR is probably an independent prognostic factor for assessment of survival rate. A correlation also exists between the grade of tumor and expression of EGFR.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Investigation of HER-2 expression and its Correlation with clinicopathological parameters and overall survival of esophageal squamous cell carcinoma patients

Background & Objective: Human epidermal growth factor receptor 2 (HER-2) exhibits a vast range of expression in esophageal squamous...

full text

Prevalence of Nucleotide Alterations of EGFR Gene in Patients with Esophageal Squamous Cell Carcinoma in Kerman

Background & Aims: Esophageal Cancer is the sixth fatal cancer in the world. Squamous and adenocarcinoma account for 95% of esophageal cancer. The expression of EGFR has a role in the pathophysiology of epidermal-based malignancies such as esophageal cancer. EGFR is also an important criterion in the evaluation of disease staging and prognosis. The aim of this study was to survey the prevalence...

full text

Cyclin D1 Expression in Patients with Laryngeal Squamous Cell Carcinoma

Background & Objective: Laryngeal squamous cell carcinoma (LSCC) is considered to be one of the most common cancers of the head and neck, accounting for roughly 90% of all malignant tumors of the larynx. To have a timely diagnosis for a better and practical therapy, molecular markers have to be investigated. The aim of this study was to determine the expression of Cyclin D1 (CD...

full text

Evaluation of Clinical, Demographic, Pathological, and Molecular Factors with Survival Rate of Patients with Oral Squamous cell Carcinoma in Yazd city During 1998–2008

Introdouction: Squamous cell carcinoma is the most common oral cancer and the prognosis because of a late diagnosis remains poor despite numerous treatments. Therefore, we conducted a cross-sectional study to investigate the relationships between survival rate(SR) of oral squamous cell carcinoma (OSCC) and clinical,demographic, pathological, and molecular factors in Yazd city during 1998–...

full text

Serum Level of Interleukin-6 in Patients with Oral Tongue Squamous cell Carcinoma

Introduction: The clinical outcome of patients with squamous cell carcinoma (SCC) located in the head and neck has remained poor despite ongoing advances in diagnosis and management. Interleukin-6(IL-6) is a multi-functional cytokine that plays an important role in the process of cell differentiation and is increased in several malignancies. The aim of this study was to investigate the serum le...

full text

Survival Rate of Patients with Squamous Cell Carcinoma of Larynx Undergoing Nonsurgical Treatments and Radiotherapy, From 2003 to 2015

Background:The incidence rate of head and neck cancer in the world is about 560,000 new cases a year. Larynx cancer is the most common malignancy in head and neck in Iran. The most common head and neck carcinoma is the malignancy of squamous epithelial cells. This study was conducted to determine the survival rate of patients undergoing nonsurgical treatment methods for larynge...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 29  issue 3

pages  110- 118

publication date 2017-07

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023